Test: African Horse Sickness (AHS) - Ab cELISA |
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
AHS (ELISA) - CVRLSR 006 - Module 4 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Positive or Negative |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
Dourine (CFT) - CVRLSR 005 - Module1 (WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.3) |
b) Test type |
Quantitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 -7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative or Positive |
j) Cut off titres |
Negative: ≤ 1:5+ Positive : ≥ 1:5++ |
Test: Equine Infectious Anaemia (EIA) - Agar Gel Immunodiffusion test (AGID/Coggins) |
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
EIA (AGID) - CVRLSR 007-Module1 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative or Positive |
Test: Equine Piroplasmosis (Babesia caballi + Theileria equi ) - Ab cELISA |
|
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
T. equi (ELISA) - CVRLSR 006 - Module 6 B.caballi (ELISA) - CVRLSR 006 - Module 7 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative or Positive |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
Glanders (CFT) - CVRLSR 005 - Module2 (WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.6.11) |
b) Test type |
Quantitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative, Inconclusive or Positive |
j) Cut off titres |
Negative: ≤ 1:2++++ Inconclusive: : ≥ 1:5+ to 1:5+++ Positive : ≥ 1:5++++ |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
Strangles (ELISA) - CVRLSR 006 - Module 2 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative, Grey area or Positive |
j) Cut off titres |
Negative: ≤ 0.2 Grey area: > 0.2 and < 0.5 Positive : ≥ 0.5 |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
West Nile (cELISA) - CVRLSR 006 - Module 5 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative, Dubious or Positive |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
West Nile IgM (ELISA) - CVRLSR 006 - Module 1 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative, Dubious or Positive |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
Brucellosis (RBT) -CVRLSR 003 (WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.1.4) |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
5 - 7ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative or Positive |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
Brucellosis (SAT) - CVRLSR 004 (WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.1.4) |
b) Test type |
Quantitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
2 - 3ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative or Positive |
j) Cut off titres |
Negative: < 1:20++ Positive : ≥ 1:20++ |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
Brucellosis (ELISA) - CVRLSR 001 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
2 - 3ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative or Positive |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
Brucellosis (CFT) - CVRLSR 002 (WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 3.1.4) |
b) Test type |
Quantitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
2 - 3ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative, Inconclusive or Positive |
j) Cut off titres |
Negative: ≤ 1:4+ Positive : ≥ 1:4++ |
Accreditation status |
ISO 17025:2017 from International Accreditation Service, US. Valid until July 2024 |
Test specifications: |
|
a) Test method |
MERS CoV (ELISA) - CVRLSR 006 - Module 10 |
b) Test type |
Qualitative |
c) Sample matrix |
Serum Samples |
d) Sample Volume/Amount |
2 - 3ml Serum |
e) Sample submission |
CVRL does not conduct site visiting and sampling. Refer ‘CVRL- Guidelines’ |
f) TAT |
4 - 5 working days |
g) Results |
Refer ‘CVRL- Guidelines’ |
h) Measurement of Uncertainty (MU) |
N/A |
i) Expression of result |
Negative, Inconclusive or Positive |